RegentAtlantic Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $34.9M | Buy |
213,405
+1,794
| +0.8% | +$304K | 1.04% | 17 |
|
|
2022
Q2 | $37.6M | Buy |
211,611
+7,172
| +4% | +$1.28M | 1.24% | 12 |
|
|
2022
Q1 | $36.2M | Buy |
204,439
+132
| +0.1% | +$22.5K | 1.02% | 18 |
|
|
2021
Q4 | $35M | Sell |
204,307
-802
| -0.4% | -$131K | 0.98% | 18 |
|
|
2021
Q3 | $33.1M | Buy |
205,109
+5,204
| +3% | +$888K | 1% | 14 |
|
|
2021
Q2 | $32.9M | Buy |
199,905
+4,223
| +2% | +$699K | 1.01% | 15 |
|
|
2021
Q1 | $32.2M | Buy |
195,682
+4,777
| +3% | +$773K | 1.09% | 13 |
|
|
2020
Q4 | $30M | Buy |
190,905
+6,909
| +4% | +$1.02M | 1.19% | 13 |
|
|
2020
Q3 | $27.4M | Buy |
183,996
+16,076
| +10% | +$2.38M | 1.23% | 14 |
|
|
2020
Q2 | $23.6M | Buy |
167,920
+1,928
| +1% | +$281K | 1.32% | 12 |
|
|
2020
Q1 | $21.8M | Buy |
165,992
+2,639
| +2% | +$374K | 1.7% | 9 |
|
|
2019
Q4 | $23.8M | Sell |
163,353
-890
| -0.5% | -$121K | 1.45% | 10 |
|
|
2019
Q3 | $21.3M | Sell |
164,243
-7,431
| -4% | -$979K | 1.4% | 10 |
|
|
2019
Q2 | $23.9M | Sell |
171,674
-7,030
| -4% | -$973K | 1.61% | 7 |
|
|
2019
Q1 | $25M | Buy |
178,704
+9,397
| +6% | +$1.26M | 1.74% | 7 |
|
|
2018
Q4 | $21.8M | Buy |
169,307
+231
| +0.1% | +$32.2K | 1.85% | 8 |
|
|
2018
Q3 | $23.4M | Sell |
169,076
-1,254
| -0.7% | -$167K | 1.79% | 4 |
|
|
2018
Q2 | $20.7M | Sell |
170,330
-9,555
| -5% | -$1.19M | 1.78% | 5 |
|
|
2018
Q1 | $23.1M | Buy |
179,885
+14,942
| +9% | +$2.02M | 1.93% | 5 |
|
|
2017
Q4 | $23M | Sell |
164,943
-3,418
| -2% | -$476K | 1.89% | 5 |
|
|
2017
Q3 | $21.9M | Sell |
168,361
-1,069
| -0.6% | -$142K | 1.89% | 4 |
|
|
2017
Q2 | $22.4M | Buy |
169,430
+3,283
| +2% | +$419K | 2.04% | 3 |
|
|
2017
Q1 | $20.7M | Sell |
166,147
-1,055
| -0.6% | -$126K | 1.92% | 5 |
|
|
2016
Q4 | $19.3M | Sell |
167,202
-2,290
| -1% | -$265K | 1.88% | 5 |
|
|
2016
Q3 | $20M | Sell |
169,492
-1,439
| -0.8% | -$175K | 2.07% | 3 |
|
|
2016
Q2 | $20.7M | Buy |
170,931
+1,744
| +1% | +$198K | 2% | 3 |
|
|
2016
Q1 | $18.3M | Sell |
169,187
-5,502
| -3% | -$570K | 2.01% | 2 |
|
|
2015
Q4 | $17.9M | Sell |
174,689
-1,491
| -0.8% | -$150K | 1.92% | 2 |
|
|
2015
Q3 | $16.4M | Sell |
176,180
-3,062
| -2% | -$296K | 1.58% | 7 |
|
|
2015
Q2 | $17.5M | Buy |
179,242
+26,407
| +17% | +$2.64M | 1.56% | 8 |
|
|
2015
Q1 | $15.4M | Buy |
152,835
+3,239
| +2% | +$329K | 1.35% | 9 |
|
|
2014
Q4 | $15.6M | Buy |
149,596
+1,476
| +1% | +$156K | 1.32% | 9 |
|
|
2014
Q3 | $15.8M | Buy |
148,120
+5,944
| +4% | +$616K | 1.48% | 8 |
|
|
2014
Q2 | $14.9M | Sell |
142,176
-424
| -0.3% | -$42.9K | 1.38% | 9 |
|
|
2014
Q1 | $14M | Buy |
142,600
+2,774
| +2% | +$257K | 1.37% | 10 |
|
|
2013
Q4 | $12.8M | Buy |
139,826
+2,573
| +2% | +$237K | 1.24% | 14 |
|
|
2013
Q3 | $11.9M | Sell |
137,253
-1,085
| -0.8% | -$97.3K | 1.3% | 12 |
|
|
2013
Q2 | $11.9M | Buy |
+138,338
| New | +$11.7M | 1.41% | 8 |
|
Other funds holding JNJ
RegentAtlantic Capital's JNJ Position: Q3 2022 in Review
RegentAtlantic Capital increased its Johnson & Johnson (JNJ) stake by 0.85% in Q3 2022, buying an estimated $304K and bringing the position to 213,405 shares worth $34.9M. The position accounts for 1.04% of the portfolio, ranked #17.
RegentAtlantic Capital first reported a position in JNJ in Q2 2013 and has held it in 38 quarters since. The position peaked at $37.6M in Q2 2022. 3,622 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.
- RegentAtlantic Capital held 213,405 shares of Johnson & Johnson worth $34.9M as of Q3 2022.
- RegentAtlantic Capital bought 1,794 Johnson & Johnson shares in Q3 2022, an estimated $304K.
- Johnson & Johnson made up 1.04% of RegentAtlantic Capital's portfolio in Q3 2022, its #17 holding.
- RegentAtlantic Capital first reported a position in Johnson & Johnson in Q2 2013 and has held it in 38 quarters since.
- RegentAtlantic Capital's Johnson & Johnson position peaked at $37.6M in Q2 2022.
- 3,622 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.
Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.